So far this year, several AI-focused companies have announced tie-ups with SPACs spanning sectors including education, diagnostics and data...
Health, Wellness & Biotech
Last year, it took $109 million to grab the 10th spot on this list — this week it took only $12 million. We know the salad days of 2021 are long...
Avestria Ventures' Linda Greub offers insider insight on the topic.
A Crunchbase analysis of the 20 largest public market debuts of venture-backed U.S. companies founded in the past 15 years reveals that only three...
Last week, a company had to raise at least $50 million to make the top 10, but not this one. One thing, however, that is similar to last — are a...
Johnson & Johnson’s spinoff, Kenvue, debuted on the stock market at $25.53 a share, a possible sign that public markets are thawing.
The Series A will help the company create a pipeline of radiopharmaceuticals starting with a treatment for prostate cancer.
![Mar Calendar page being torn off to make way for Apr. [Dom Guman]](https://news.crunchbase.com/wp-content/uploads/mar-apr-2-470x352.jpg)
Global venture funding in April reached $21 billion, the second-lowest amount recorded in a single month since July 2022.
Large deals were plentiful this week, as U.S.-based startups raised five nine-figure rounds — with two of those going to biotech startups. In fact...
Each year, in the U.S. alone, hundreds of funded startups get acquired by private, venture-backed companies. This year is shaping up as no exception.
After a bumpy first quarter for venture capital, the second quarter is in full swing. Here's a handful of rounds that may have been overlooked.
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers